RCEL - Avita Medical Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
+0.46 (+4.43%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close10.39
Bid0.00 x 800
Ask0.00 x 1200
Day's Range10.68 - 10.92
52 Week Range1.84 - 10.92
Avg. Volume496,631
Market Cap1.053B
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Press Releases
  • Business Wire

    AVITA Medical to Present at the Cowen 40th Annual Health Care Conference

    AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is being made on 4 March 2020 from 9:20 a.m. to 9:50 a.m. EST at the Boston Marriott Copley Place hotel. Interested parties may access a webcast of the presentation on the "Investors" section of the company’s website at: https://www.avitamedical.com/investors.

  • Business Wire

    AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update

    AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal second quarter ended 31 December 2019 today in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange (ASX).